Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA236145
Max Phase: Preclinical
Molecular Formula: C11H7BrN6O2S2
Molecular Weight: 399.26
Molecule Type: Small molecule
Associated Items:
ID: ALA236145
Max Phase: Preclinical
Molecular Formula: C11H7BrN6O2S2
Molecular Weight: 399.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N/N=C1\C(=O)Nc2ccc(Br)cc21)Nc1n[nH]c(=S)s1
Standard InChI: InChI=1S/C11H7BrN6O2S2/c12-4-1-2-6-5(3-4)7(8(19)13-6)15-16-9(20)14-10-17-18-11(21)22-10/h1-3H,(H,18,21)(H,13,15,19)(H2,14,16,17,20)
Standard InChI Key: QWOSHSULVITANU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 399.26 | Molecular Weight (Monoisotopic): 397.9255 | AlogP: 2.44 | #Rotatable Bonds: 2 |
Polar Surface Area: 111.27 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.23 | CX Basic pKa: | CX LogP: 2.64 | CX LogD: 2.31 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.46 | Np Likeness Score: -1.83 |
1. Abdel-Hamid MK, Abdel-Hafez AA, El-Koussi NA, Mahfouz NM, Innocenti A, Supuran CT.. (2007) Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity., 15 (22): [PMID:17822907] [10.1016/j.bmc.2007.07.044] |
2. Pan P, Vermelho AB, Capaci Rodrigues G, Scozzafava A, Tolvanen ME, Parkkila S, Capasso C, Supuran CT.. (2013) Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease., 56 (4): [PMID:23391336] [10.1021/jm4000616] |
3. Syrjänen L, Vermelho AB, Rodrigues Ide A, Corte-Real S, Salonen T, Pan P, Vullo D, Parkkila S, Capasso C, Supuran CT.. (2013) Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis., 56 (18): [PMID:23977960] [10.1021/jm400939k] |
Source(1):